Wang, Shuaiwei https://orcid.org/0000-0002-1659-8962
Barry, Allison M. https://orcid.org/0000-0002-6787-6889
Lee, Yoon Kyung https://orcid.org/0009-0002-7466-8233
Young, Naomi https://orcid.org/0009-0001-6257-7185
Shim, Sang Wook https://orcid.org/0009-0001-3326-4673
Wang, Xinying
Kim, Hyeongcheol https://orcid.org/0000-0003-4327-2148
Stirling-Barros, Laura https://orcid.org/0009-0004-1453-6743
González-Cano, Rafael https://orcid.org/0000-0002-9657-4521
Costigan, Michael
Baskozos, Georgios https://orcid.org/0000-0001-9237-5878
Rinaldi, Simon https://orcid.org/0000-0003-2039-3457
Bennett, David LH https://orcid.org/0000-0002-7996-2696
Oh, Seog Bae https://orcid.org/0000-0001-7975-6895
Davies, Alexander J. https://orcid.org/0000-0003-0072-1708
Funding for this research was provided by:
Wellcome Trust (215145/Z/18/Z)
Wellcome Trust (223149/Z/21/Z)
UK Research and Innovation (MR/P008399/1)
UK Research and Innovation (MR/T020113/1)
UK Research and Innovation (MR/V02552X/1)
National Research Foundation of Korea (RS-2023-00264409)
Article History
Received: 15 July 2025
Accepted: 25 October 2025
First Online: 29 December 2025
Declarations
:
: A.J.D. and S.B.O. are named on a patent pending (US20210121501A) for the use of immune cells in the treatment of nerve injury. S.B.O. is founder of OhLabBio. A.J.D. receives funding from Elasmogen. All other authors declare no conflict of interest.